Navigation Links
Society of Interventional Radiology Foundation Welcomes Corporate Gift From Sirtex Medical
Date:8/16/2011

FAIRFAX, Va., Aug. 16, 2011 /PRNewswire-USNewswire/ -- The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Sirtex Medical Inc.—a medical devices company that researches, develops and brings to market novel treatments for liver cancer using small particle technology and has its U.S. headquarters in Wilmington, Mass.—has pledged $50,000 and is a "Partner in Research" supporter.

(Logo: http://photos.prnewswire.com/prnh/20100127/SIRLOGO)

"With this commitment of support, Sirtex makes a solid investment in the education and training of the next generation of interventional radiologists," said Gordon McLennan, M.D., FSIR, chair of the SIRF board of directors and an interventional radiologist with the Cleveland Clinic in Cleveland, Ohio. He added that funding will be used to support grants, research consensus panels, registries, studies addressing comparative effectiveness, clinical trials and educational programming. "One of the major priorities of the SIR Foundation is to increase support for cutting-edge research. We thank Sirtex Medical for coming forward to support us on this venture," he noted.

"Sirtex Medical is proud to continue our long-standing relationship with SIR through this pledge to the SIR Foundation," said Michael Mangano, the company's president. "We are committed to the ongoing education and training of interventional radiologists to ensure that the high level of quality that this important discipline is renowned for can continue," he added.

The Discovery Campaign was launched initially in 2007 with an SIR membership phase. Last year marked the initiation of the campaign's outreach to the medical technology industry for support. For information about the Society of Interventional Radiology, a national organization of nearly 4,700 doctors, scientists and allied health professionals dedicated to improving health care through minimally invasive treatments, visit online at www.SIRweb.org. For more information about the Discovery Campaign or to learn more about the Society of Interventional Radiology Foundation, visit online at www.SIRFoundation.org.

About the Society of Interventional Radiology Foundation

SIR Foundation is a scientific foundation dedicated to fostering research and education in interventional radiology for the purposes of advancing scientific knowledge, increasing the number of skilled investigators in interventional radiology and developing innovative therapies that lead to improved patient care and quality of life. Visit www.SIRFoundation.org.

About Sirtex Medical

Sirtex Medical, Inc. manufactures and commercializes SIR-Spheres microspheres, the only FDA-approved Selective Internal Radiation Therapy (SIRT) for the treatment of colorectal cancer that has spread to the liver. SIR-Spheres microspheres are FDA approved for the treatment of non-resectable metastatic colorectal cancer in combination with intra-arterial FUDR chemotherapy. SIR-Spheres microspheres are also approved for use in many other countries, with approximately 18,000 treatments worldwide. For more information, visit www.sirtex.com.


'/>"/>
SOURCE Society of Interventional Radiology
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Elsevier Collaborates with the Wilderness Medicine Society to Award Outstanding Members
2. NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society
3. The Pittsburgh Life Sciences Greenhouse Announces Innovative Partnership With University of Pittsburgh Biomedical Engineering Society
4. Neurologix Presents One-Year Follow-Up Data From Phase 2 Study of NLX-P101 in Parkinsons Disease at International Neuromodulation Society 10th World Congress
5. Northwest Biotherapeutics to Present at American Society of Cell and Gene Therapy
6. Ardea Biosciences Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at 2011 American Society of Clinical Oncology Annual Meeting
7. InterMune Announces Presentation of Positive Pirfenidone Data at the International Conference of the American Thoracic Society (ATS)
8. Jennerex to Present JX-594 Liver Cancer Clinical Data at American Society of Gene and Cell Therapy Meeting
9. The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting
10. The Leukemia & Lymphoma Society: Accelerating Cures Must Be a Priority
11. Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Media Cybernetics, ... new Media Cybernetics corporate branding reflects a results-driven revitalization for a company with ... The re-branding components include a crisp, refreshed logo and a new web presence. ...
(Date:5/23/2016)... WARSAW, Ind. , May 23, 2016 Zimmer ... in musculoskeletal healthcare, today announced that its Board of Directors ... stockholders for the second quarter of 2016. ... on or about July 29, 2016 to stockholders of record ... Future declarations of dividends are subject to approval of the ...
(Date:5/23/2016)... ... May 23, 2016 , ... RoviSys, a leading independent provider ... Ohio, has broken ground on a new building in Holly Springs, NC. With ... new location solidifies a commitment to business in the region. The new facility ...
(Date:5/20/2016)... Diego, CA (PRWEB) , ... May 20, 2016 , ... ... that 10 of its most experienced veterinary clients have treated over 100 of their ... cutting edge technology to provide the highest level of care for their patients. ...
Breaking Biology Technology:
(Date:3/11/2016)... , March 11, 2016 http://www.apimages.com ) - ... reference: Picture is available at AP Images ( http://www.apimages.com ) - ... will be used to produce the new refugee identity cards. DERMALOG ... innovations, at CeBIT in Hanover next week.   ... DERMALOG will be used to produce the new refugee identity cards. ...
(Date:3/10/2016)... , March 10, 2016   Unisys Corporation ... and Border Protection (CBP) is testing its biometric identity ... San Diego to help identify certain non-U.S. citizens ... . The test, designed to help determine the efficiency and ... began in February and will run until May 2016. ...
(Date:3/9/2016)... , March 9, 2016  Crossmatch ® , ... enrollment solutions, today announced the addition of smart ... Altus multi-factor authentication platform. New contextual and ... to step-up security where it,s needed most — ... Washington, DC . --> ...
Breaking Biology News(10 mins):